索非布韦药物中国授权专利分析

Analysis of Granted Patents of Sofosbuvir Drugs in China

索非布韦是美国吉利德科学公司开发的新一代HCV聚合酶抑制剂,是一种抗丙肝病毒药物。本文分别从晶型、药物组合物、衍生物、制备方法、中间体及其制备方法、联合用药以及其他相关主题对索非布韦药物中国授权专利进行分析,为国内企业制定专利战略提供参考。

Sofosbuvir is a new generation of HCV polymerase inhibitor developed by Gilead Science,Inc.,and is an anti-HCV drug. This paper analyzes the granted patents to sofosbuvir from crystalline forms,pharmaceutical compositions,derivatives,preparation methods,intermediates and their preparation methods,combination drugs and other related topics,and provides reference for domestic enterprises to develop patent strategies.